+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
From
Systemic Lupus Erythematosus Treatment Global Market Report 2024 - Product Thumbnail Image

Systemic Lupus Erythematosus Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook to 2035 - Product Thumbnail Image

Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook to 2035

  • Report
  • February 2023
  • 243 Pages
  • Asia Pacific
From
From
Alzheimer's Disease Therapeutics Market 2024-2028 - Product Thumbnail Image

Alzheimer's Disease Therapeutics Market 2024-2028

  • Report
  • November 2023
  • 168 Pages
  • Global
From
From
Rheumatoid Arthritis Drugs Global Market Report 2024 - Product Thumbnail Image

Rheumatoid Arthritis Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Osteoporosis Treatment Global Market Report 2024 - Product Thumbnail Image

Osteoporosis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Loading Indicator